Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma

Sheen-Yie Fang, Van Jin-Jou, Masuru Ohyama

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Gene mutation of p53 is documented in head and neck cancer. No répons exist relating human sinonasal inverted papilloma (IP) and its transformation to squamous cell carcinoma (SCC). Using immunohistochemical techniques improved by an antigen retrieval method, p53 protein was analyzed in the following subjects: 16 IP, 12 SCC arising in IP, and 15 SCC alone subjects. Both the intensity (PI) and rate (PR) of positive p53 immunostaining were evaluated using a quantitative AutoCAD program. We correlated p53 protein expression with clinical features. p53 immunoreactivity is significantly lower in IP than in SCC specimens. Both the IP and SCC portions of IP synchronous SCC subjects showed similar p53 protein expression. SCC arising in IP shows a lower p53 immunoreactivity than SCC alone. Alteration of p53 protein mav have an important role in the early stages of IP malignant transformation and prove a potential biomarker for risk assessment. Low p53 immunoreactivity, indicating the presence of a wild-type p53, may correlate with the prognosis for SCC arising in IP. However, further clinical trials are required to investigate this possibly worthwhile prognostic marker.

Original languageEnglish
Pages (from-to)119-124
Number of pages6
JournalAmerican Journal of Rhinology
Volume12
Issue number2
DOIs
Publication statusPublished - 1998 Jan 1

Fingerprint

Inverted Papilloma
Squamous Cell Carcinoma
Immunohistochemistry
Proteins
p53 Genes
Head and Neck Neoplasms
Biomarkers
Clinical Trials
Antigens

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{01a3d84330c8401590aa97e8e4562c1b,
title = "Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma",
abstract = "Gene mutation of p53 is documented in head and neck cancer. No r{\'e}pons exist relating human sinonasal inverted papilloma (IP) and its transformation to squamous cell carcinoma (SCC). Using immunohistochemical techniques improved by an antigen retrieval method, p53 protein was analyzed in the following subjects: 16 IP, 12 SCC arising in IP, and 15 SCC alone subjects. Both the intensity (PI) and rate (PR) of positive p53 immunostaining were evaluated using a quantitative AutoCAD program. We correlated p53 protein expression with clinical features. p53 immunoreactivity is significantly lower in IP than in SCC specimens. Both the IP and SCC portions of IP synchronous SCC subjects showed similar p53 protein expression. SCC arising in IP shows a lower p53 immunoreactivity than SCC alone. Alteration of p53 protein mav have an important role in the early stages of IP malignant transformation and prove a potential biomarker for risk assessment. Low p53 immunoreactivity, indicating the presence of a wild-type p53, may correlate with the prognosis for SCC arising in IP. However, further clinical trials are required to investigate this possibly worthwhile prognostic marker.",
author = "Sheen-Yie Fang and Van Jin-Jou and Masuru Ohyama",
year = "1998",
month = "1",
day = "1",
doi = "10.2500/105065898781390235",
language = "English",
volume = "12",
pages = "119--124",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "2",

}

Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma. / Fang, Sheen-Yie; Jin-Jou, Van; Ohyama, Masuru.

In: American Journal of Rhinology, Vol. 12, No. 2, 01.01.1998, p. 119-124.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma

AU - Fang, Sheen-Yie

AU - Jin-Jou, Van

AU - Ohyama, Masuru

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Gene mutation of p53 is documented in head and neck cancer. No répons exist relating human sinonasal inverted papilloma (IP) and its transformation to squamous cell carcinoma (SCC). Using immunohistochemical techniques improved by an antigen retrieval method, p53 protein was analyzed in the following subjects: 16 IP, 12 SCC arising in IP, and 15 SCC alone subjects. Both the intensity (PI) and rate (PR) of positive p53 immunostaining were evaluated using a quantitative AutoCAD program. We correlated p53 protein expression with clinical features. p53 immunoreactivity is significantly lower in IP than in SCC specimens. Both the IP and SCC portions of IP synchronous SCC subjects showed similar p53 protein expression. SCC arising in IP shows a lower p53 immunoreactivity than SCC alone. Alteration of p53 protein mav have an important role in the early stages of IP malignant transformation and prove a potential biomarker for risk assessment. Low p53 immunoreactivity, indicating the presence of a wild-type p53, may correlate with the prognosis for SCC arising in IP. However, further clinical trials are required to investigate this possibly worthwhile prognostic marker.

AB - Gene mutation of p53 is documented in head and neck cancer. No répons exist relating human sinonasal inverted papilloma (IP) and its transformation to squamous cell carcinoma (SCC). Using immunohistochemical techniques improved by an antigen retrieval method, p53 protein was analyzed in the following subjects: 16 IP, 12 SCC arising in IP, and 15 SCC alone subjects. Both the intensity (PI) and rate (PR) of positive p53 immunostaining were evaluated using a quantitative AutoCAD program. We correlated p53 protein expression with clinical features. p53 immunoreactivity is significantly lower in IP than in SCC specimens. Both the IP and SCC portions of IP synchronous SCC subjects showed similar p53 protein expression. SCC arising in IP shows a lower p53 immunoreactivity than SCC alone. Alteration of p53 protein mav have an important role in the early stages of IP malignant transformation and prove a potential biomarker for risk assessment. Low p53 immunoreactivity, indicating the presence of a wild-type p53, may correlate with the prognosis for SCC arising in IP. However, further clinical trials are required to investigate this possibly worthwhile prognostic marker.

UR - http://www.scopus.com/inward/record.url?scp=0032020503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032020503&partnerID=8YFLogxK

U2 - 10.2500/105065898781390235

DO - 10.2500/105065898781390235

M3 - Article

C2 - 9578930

AN - SCOPUS:0032020503

VL - 12

SP - 119

EP - 124

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 2

ER -